- Home
- KFFB vs TENX Comparison
KFFB vs TENX Comparison
Compare KFFB & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KFFB
- TENX
- Stock Information
- Founded
- KFFB 2005
- TENX 1967
- Country
- KFFB United States
- TENX United States
- Employees
- KFFB N/A
- TENX N/A
- Industry
- KFFB Savings Institutions
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- KFFB Finance
- TENX Health Care
- Exchange
- KFFB Nasdaq
- TENX Nasdaq
- Market Cap
- KFFB 24.1M
- TENX 19.5M
- IPO Year
- KFFB 2005
- TENX N/A
- Fundamental
- Price
- KFFB $2.66
- TENX $5.52
- Analyst Decision
- KFFB
- TENX Strong Buy
- Analyst Count
- KFFB 0
- TENX 4
- Target Price
- KFFB N/A
- TENX $20.67
- AVG Volume (30 Days)
- KFFB 7.9K
- TENX 67.4K
- Earning Date
- KFFB 02-10-2025
- TENX 11-13-2024
- Dividend Yield
- KFFB N/A
- TENX N/A
- EPS Growth
- KFFB N/A
- TENX N/A
- EPS
- KFFB N/A
- TENX N/A
- Revenue
- KFFB $7,475,000.00
- TENX N/A
- Revenue This Year
- KFFB N/A
- TENX N/A
- Revenue Next Year
- KFFB N/A
- TENX N/A
- P/E Ratio
- KFFB N/A
- TENX N/A
- Revenue Growth
- KFFB N/A
- TENX N/A
- 52 Week Low
- KFFB $2.50
- TENX $2.77
- 52 Week High
- KFFB $4.83
- TENX $27.36
- Technical
- Relative Strength Index (RSI)
- KFFB 45.83
- TENX 52.17
- Support Level
- KFFB $2.75
- TENX $5.70
- Resistance Level
- KFFB $3.00
- TENX $6.01
- Average True Range (ATR)
- KFFB 0.14
- TENX 0.48
- MACD
- KFFB 0.01
- TENX -0.06
- Stochastic Oscillator
- KFFB 19.05
- TENX 17.65
About KFFB Kentucky First Federal Bancorp
Kentucky First Federal Bancorp is a holding company. The company through its subsidiaries is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans and types of deposits, etc. The company mainly operates in Perry, Franklin, Boyle and Garrard and surrounding counties in Kentucky, US.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.